Clinical Trial Update: Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating allogeneic hematopoietic cell transplantation for peripheral T-cell lymphoma; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoproliferative Disorders
• Peripheral T-cell Lymphoma

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Peripheral T-cell Lymphomas, Lymphoproliferative Disorders | Phase 2 | Status: RECRUITING